EPISODE · Mar 31, 2026 · 7 MIN
2353: Poolbeg Pharma Secures First Oncology Patent for POLB 001
from The Vox Markets Podcast · host Vox Markets Podcast
Poolbeg Pharma announces its first granted patent for POLB 001 in cancer immunotherapy-induced CRS, strengthening its global IP position. The milestone supports future partnering opportunities as the company advances toward key clinical data in 2026.
NOW PLAYING
2353: Poolbeg Pharma Secures First Oncology Patent for POLB 001
0:00
7:04
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Vox Markets Podcast?
This episode is 7 minutes long.
When was this The Vox Markets Podcast episode published?
This episode was published on March 31, 2026.
What is this episode about?
Poolbeg Pharma announces its first granted patent for POLB 001 in cancer immunotherapy-induced CRS, strengthening its global IP position. The milestone supports future partnering opportunities as the company advances toward key clinical data in 2026.
Can I download this The Vox Markets Podcast episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!